Viewing StudyNCT03126435

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 9:57 AM
Last Modification Date: 2024-10-26 @ 12:22 PM
Study NCT ID: NCT03126435
Status: COMPLETED
Last Update Posted: 2023-05-06
First Post: 2017-04-19
Brief Title: EndoTAG-1GEM vs GEM in Patients With Locally AdvancedMetastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX
Sponsor: SynCore Biotechnology Co Ltd
Organization: SynCore Biotechnology Co Ltd
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Metastatic Pancreas Cancer
Locally Advanced Pancreatic Cancer
Pancreatic Adenocarcinoma
Keywords:
Name View
Gemcitabine View
FOLFIRINOX View
5-Fluorouracil View
folinic acid View
irinotecan View
oxaliplatin View